KRRO – korro bio, inc. (US:NASDAQ)

News

Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
Korro to Participate in Upcoming June Investor and Scientific Conferences
Korro Bio, Inc. (NASDAQ: KRRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Forbion-backed biotech Progentos debuts with $65M for MS drug [Yahoo! Finance]
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com